» Articles » PMID: 28631160

Role of Imaging in the Follow-up of T2-T3 Glottic Cancer Treated by Transoral Laser Microsurgery

Overview
Date 2017 Jun 21
PMID 28631160
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

An unblinded retrospective analysis of prospectively collected data was carried out on 138 patients affected by glottic pT2 and selected pT3 squamous cell carcinomas (SCC) treated by transoral laser microsurgery (TLM). The entire cohort was divided into two groups: Group A included 78 "high-risk" patients (pT2 with impaired vocal cord mobility, pT3 for anterior paraglottic and/or pre-epiglottic space invasion, presence of angioembolization, perineural spread, and positive lymph nodes in the neck) who underwent postoperative surveillance by endoscopy and imaging (CT or MR), while Group B included 60 "low-risk" patients (pT2 with absence of the above-mentioned features) who underwent endoscopic follow-up alone. Aim of the present study was to assess the diagnostic gain in performing combined endoscopic and radiologic surveillance in the "high-risk" group compared to endoscopy alone in the "low-risk" one. There was no significant difference in terms of overall and disease-specific survivals between the two follow-up policies in spite of their different risk profiles. The same was true for organ preservation rate, which was 81% in the "high-risk" and 89% in the "low-risk" group. In contrast, the cumulative probability of disease-free survival was 54% for Group A and 65% for Group B (p = 0.0023). Therefore, our combined endoscopy and imaging surveillance protocol allowed increasing the submucosal recurrence detection rate in "high-risk" pT2-pT3 glottic SCC to 43%. An earlier detection of submucosal recurrences made salvage surgery by TLM feasible in at least half of cases, thus closing the gap between oncologic outcomes obtained in "high-"- vs. "low-risk" patients and leading to organ preservation rates that are favorably comparable to those obtained with open-neck partial laryngectomies and non-surgical organ preservation protocols.

Citing Articles

Post-treatment surveillance imaging in head and neck cancer: a systematic review.

Van Hoe S, Hermans R Insights Imaging. 2024; 15(1):32.

PMID: 38315325 PMC: 10844183. DOI: 10.1186/s13244-023-01578-4.


Magnetic resonance imaging to assess cartilage invasion in recurrent laryngeal carcinoma after transoral laser microsurgery.

Ravanelli M, Lancini D, Maroldi R, Paderno A, Rondi P, Battocchio S Acta Otorhinolaryngol Ital. 2023; 42(6):531-537.

PMID: 36654519 PMC: 9853105. DOI: 10.14639/0392-100X-N2090.


Transoral Laser Microsurgery for Glottic Cancer in Patients Over 75 Years Old.

Paderno A, Lancini D, Bosio P, Del Bon F, Fior M, Berretti G Laryngoscope. 2021; 132(1):135-141.

PMID: 34233029 PMC: 9291037. DOI: 10.1002/lary.29738.


Introduction of a New Pathology Workup Protocol for Glottic Cancer Treated With Transoral Laser Microsurgery (TLM): Prospective Analysis of Oncological Outcomes and Matched Case-Control Study.

Meulemans J, Narimani S, Hauben E, Nuyts S, Laenen A, Delaere P Front Oncol. 2021; 11:685255.

PMID: 34017690 PMC: 8130557. DOI: 10.3389/fonc.2021.685255.


A Multidisciplinary Team Guided Approach to the Management of cT3 Laryngeal Cancer: A Retrospective Analysis of 104 Cases.

Marchi F, Filauro M, Missale F, Parrinello G, Incandela F, Bacigalupo A Cancers (Basel). 2019; 11(5).

PMID: 31137671 PMC: 6562846. DOI: 10.3390/cancers11050717.


References
1.
Simo R, Bradley P, Chevalier D, Dikkers F, Eckel H, Matar N . European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol. 2014; 271(9):2469-79. DOI: 10.1007/s00405-014-2966-x. View

2.
Peretti G, Piazza C, Mora F, Garofolo S, Guastini L . Reasonable limits for transoral laser microsurgery in laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2016; 24(2):135-9. DOI: 10.1097/MOO.0000000000000240. View

3.
Joshi V, Wadhwa V, Mukherji S . Imaging in laryngeal cancers. Indian J Radiol Imaging. 2013; 22(3):209-26. PMC: 3624744. DOI: 10.4103/0971-3026.107183. View

4.
Ansarin M, Cattaneo A, De Benedetto L, Zorzi S, Lombardi F, Alterio D . Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery. Head Neck. 2016; 39(1):71-81. DOI: 10.1002/hed.24534. View

5.
Hermans R . Post-treatment imaging of head and neck cancer. Cancer Imaging. 2008; 4 Spec No A:S6-S15. PMC: 1435341. DOI: 10.1102/1470-7330.2004.0007. View